EUCTR2012-001757-21-SE进行中（未招募）1 期
European Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial - ESH-CHL-SHOT
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 7,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Stroke or transient ischaemic attack during the previous 1 to 6 months; Age 65 years or older; Hypertension (>140/90 mm Hg among untreated patients); Hyperlipidaemia (LDL-cholesterol >2.8 mmol/L among untreated patients)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 7500
排除标准
- •1) Significant carotid artery stenosis; 2) Secondary hypertension or treatment resistant hypertension; 3) Treatment resistant hyperlipidaemia; 4) Dementia; 5) Functional disability (modified Rankin Scale score >4); 6) Renal failure or liver disease; 7) Reduced compliance.
研究者
相似试验
进行中（未招募）
1 期
Optimal treatment for preventing recurrent stroke in hypertensivesPatients with arterial hypertension and previous stroke or transient ischemic attackMedDRA version: 15.0Level: SOCClassification code 10047065Term: Vascular disordersSystem Organ Class: 10047065 - Vascular disordersEUCTR2012-001757-21-ITISTITUTO AUXOLOGICO ITALIANO7,500
已完成
4 期
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in HypertensivesStrokeHypertensionTransient Ischemic AttackNCT01563731Istituto Auxologico Italiano200
撤回
不适用
eo* Randomized Hypertension Studyrefractory high blood pressuretherapy-resistant hypertension10057166NL-OMON37975CVRx Inc25
招募中
不适用
Hypertension Registry of "Hypertension Prevention and Control Initiative in China"HypertensionNCT04289701Chinese Academy of Medical Sciences, Fuwai Hospital200,000
Unknown
不适用
The Chinese Early-onset Hypertension Study (CHESS)HypertensionNCT02819674China National Center for Cardiovascular Diseases5,000